ALEXANDRIA, Va., July 3 -- United States Patent no. 12,343,395, issued on July 1, was assigned to Trizell GmbH (Hamburg, Germany).
"Regulatory macrophages for treating angiopathies" was invented by Fred Fandrich (Kiel, Germany).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to the use of immunoregulatory macrophages for treating diseases that are associated with pathological changes of the blood vessels. The present invention particularly relates to the use of immunoregulatory macrophages for treating micro- and macroangiopathies of the lower limbs. The invention furthermore relates to the use of immunoregulatory macrophages for promoting tissue remodelling to facilitate wound he...